TIMP1 and infection: Considering the antagonistic functionality of MMP9 and TIMP-1, these data suggest that our control animals may still be actively remodeling lung tissue to combat infection, while the UA-treated animals with altered IL-17 signaling may be resolving the lung environment to repair functionality.